314 related articles for article (PubMed ID: 10208170)
1. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data.
Allingham-Hawkins DJ; Babul-Hirji R; Chitayat D; Holden JJ; Yang KT; Lee C; Hudson R; Gorwill H; Nolin SL; Glicksman A; Jenkins EC; Brown WT; Howard-Peebles PN; Becchi C; Cummings E; Fallon L; Seitz S; Black SH; Vianna-Morgante AM; Costa SS; Otto PA; Mingroni-Netto RC; Murray A; Webb J; Vieri F
Am J Med Genet; 1999 Apr; 83(4):322-5. PubMed ID: 10208170
[TBL] [Abstract][Full Text] [Related]
2. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data.
Uzielli ML; Guarducci S; Lapi E; Cecconi A; Ricci U; Ricotti G; Biondi C; Scarselli B; Vieri F; Scarnato P; Gori F; Sereni A
Am J Med Genet; 1999 May; 84(3):300-3. PubMed ID: 10331612
[TBL] [Abstract][Full Text] [Related]
3. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations.
Hundscheid RD; Sistermans EA; Thomas CM; Braat DD; Straatman H; Kiemeney LA; Oostra BA; Smits AP
Am J Hum Genet; 2000 Feb; 66(2):413-8. PubMed ID: 10677300
[TBL] [Abstract][Full Text] [Related]
4. Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry.
Utine GE; Şimşek-Kiper PÖ; Akgün-Doğan Ö; Ürel-Demir G; Alanay Y; Aktaş D; Boduroğlu K; Tunçbilek E; Alikaşifoğlu M
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():76-80. PubMed ID: 29275276
[TBL] [Abstract][Full Text] [Related]
5. X chromosome inactivation does not define the development of premature ovarian failure in fragile X premutation carriers.
Spath MA; Nillesen WN; Smits AP; Feuth TB; Braat DD; van Kessel AG; Yntema HG
Am J Med Genet A; 2010 Feb; 152A(2):387-93. PubMed ID: 20101683
[TBL] [Abstract][Full Text] [Related]
6. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives.
Hundscheid RD; Braat DD; Kiemeney LA; Smits AP; Thomas CM
Hum Reprod; 2001 Mar; 16(3):457-62. PubMed ID: 11228211
[TBL] [Abstract][Full Text] [Related]
7. Predictors and risk model development for menopausal age in fragile X premutation carriers.
Spath MA; Feuth TB; Smits AP; Yntema HG; Braat DD; Thomas CM; van Kessel AG; Sherman SL; Allen EG
Genet Med; 2011 Jul; 13(7):643-50. PubMed ID: 21597380
[TBL] [Abstract][Full Text] [Related]
8. Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions.
Mailick MR; Hong J; Greenberg J; Smith L; Sherman S
Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):705-11. PubMed ID: 25346430
[TBL] [Abstract][Full Text] [Related]
9. Association between idiopathic premature ovarian failure and fragile X premutation.
Marozzi A; Vegetti W; Manfredini E; Tibiletti MG; Testa G; Crosignani PG; Ginelli E; Meneveri R; Dalprà L
Hum Reprod; 2000 Jan; 15(1):197-202. PubMed ID: 10611212
[TBL] [Abstract][Full Text] [Related]
10. Fragile X premutation in women with sporadic premature ovarian failure in Slovenia.
Gersak K; Meden-Vrtovec H; Peterlin B
Hum Reprod; 2003 Aug; 18(8):1637-40. PubMed ID: 12871874
[TBL] [Abstract][Full Text] [Related]
11. Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency.
Hoyos LR; Thakur M
J Assist Reprod Genet; 2017 Mar; 34(3):315-323. PubMed ID: 27995424
[TBL] [Abstract][Full Text] [Related]
12. Evidence of early ovarian aging in fragile X premutation carriers.
Welt CK; Smith PC; Taylor AE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4569-74. PubMed ID: 15356064
[TBL] [Abstract][Full Text] [Related]
13. The ovarian response in fragile X patients and premutation carriers undergoing IVF-PGD: reappraisal.
Avraham S; Almog B; Reches A; Zakar L; Malcov M; Sokolov A; Alpern S; Azem F
Hum Reprod; 2017 Jul; 32(7):1508-1511. PubMed ID: 28472405
[TBL] [Abstract][Full Text] [Related]
14. Premature ovarian failure and fragile X premutation: a study on 45 women.
Bussani C; Papi L; Sestini R; Baldinotti F; Bucciantini S; Bruni V; Scarselli G
Eur J Obstet Gynecol Reprod Biol; 2004 Feb; 112(2):189-91. PubMed ID: 14746957
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women.
Murray A; Webb J; MacSwiney F; Shipley EL; Morton NE; Conway GS
Hum Reprod; 1999 May; 14(5):1217-8. PubMed ID: 10325264
[TBL] [Abstract][Full Text] [Related]
16. Premature ovarian failure in the fragile X syndrome.
Sherman SL
Am J Med Genet; 2000; 97(3):189-94. PubMed ID: 11449487
[TBL] [Abstract][Full Text] [Related]
17. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure.
Hundscheid RD; Smits AP; Thomas CM; Kiemeney LA; Braat DD
Am J Med Genet A; 2003 Feb; 117A(1):6-9. PubMed ID: 12548733
[TBL] [Abstract][Full Text] [Related]
18. No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers.
Murray A; Ennis S; Morton N
Am J Hum Genet; 2000 Jul; 67(1):253-4; author reply 256-8. PubMed ID: 10848495
[No Abstract] [Full Text] [Related]
19. Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?
Sherman SL
Am J Hum Genet; 2000 Jul; 67(1):11-3. PubMed ID: 10848491
[No Abstract] [Full Text] [Related]
20. Fragile X premutations are not a major cause of early menopause.
Kenneson A; Cramer DW; Warren ST
Am J Hum Genet; 1997 Dec; 61(6):1362-9. PubMed ID: 9399905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
